Zacks Investment Research on MSN
Rare, MREO tank as osteogenesis study fails to meet primary endpoint
Shares of Ultragenyx Pharmaceutical RARE and Mereo BioPharma MREO plunged 42.3% and 87.6%, respectively, on Dec. 29 after the ...
When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...
TipRanks on MSN
Amgen’s long-term pediatric psoriasis study on apremilast: Why the latest update matters for investors
Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Extends Pediatric Psoriasis Study: What ...
Artificial intelligence (AI) is rapidly advancing across modern healthcare, yet its role in pediatric surgery remains limited ...
Children’s Hospital has secured more than $3.2 million in grant funding to support new research in pediatric neurology, cardiology, lung disease and infectious disease. The Arizona Biomedical Research ...
The results suggest room for improvement in Canadian trauma systems to ensure that all children receive optimal care, ...
Despite missing the primary endpoint in a pediatric study, Agios says it remains steadfast in working to grow the reach of its pyruvate kinase (PK) activation franchise. Agios hopes to fill the ...
In a recent study published in the journal Pediatrics, a team of researchers in the United States (U.S.) conducted a cross-sectional study to understand the trends in antiviral usage among adolescents ...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...
A clinical study with children as participants entails extra costs often omitted in the initial budget. Clinical studies involving children are thus at risk of being undercompensated, new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results